ABSTRACT
Neonatal abstinence syndrome (NAS) affects thousands of babies per year, is growing in prevalence, affects all socioeconomic, cultural and racial demographics, and represents a transdisciplinary challenge. Acute complications of NAS include withdrawal symptoms, seizures, and potentially death; however, effective management can minimize the risk to nearly zero. Long-term complications of NAS are not fully characterized yet, but evidence suggests they may include neurocognitive and behavioral impairments. Creating effective, collaborative partnerships between the care team and the infant-mother dyad is the primary driver of success in treating NAS. Effective partnerships between social support services, community resources, and medical care teams are critical to successful care and optimized neurodevelopmental outcomes.
